The accuracy of 18FDG-PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCI

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2013-07-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD010632
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles

  2014cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes

  2010cited by this paper
• Revising the definition of Alzheimer's disease: a new lexicon.

  2010cited by this paper
• Early Detection of Brain Pathology Suggestive of Early AD Using Objective Evaluation of FDG-PET Scans

  2010cited by this paper
• Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative

  2010cited by this paper
• IC‐P‐113: Early Detection of Changes Consistent with AD Using Objective Evaluation of FDG‐PET Scans

  2010cited by this paper
• EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2

  2009cited by this paper
• Mild cognitive impairment: ten years later.

  2009cited by this paper
• FDG PET in the Evaluation of Mild Cognitive Impairment and Early Dementia

  2009cited by this paper
• Microglial activation and amyloid deposition in mild cognitive impairment

  2009cited by this paper
• Neural correlates of Alzheimer's disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients

  2009cited by this paper
• Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study

  2009cited by this paper
• CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

  2009cited by this paper
• Systematic Reviews of Diagnostic Test Accuracy

  2008cited by this paper
• Two‐Year Progression from Mild Cognitive Impairment to Dementia: To What Extent Do Different Definitions Agree?

  2008cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

  2006cited by this paper
• Memantine for dementia.

  2006cited by this paper
• Neurochemical Imaging with Emission Tomography: Clinical Applications

  2006cited by this paper
• Cholinesterase inhibitors for Alzheimer's disease.

  2006cited by this paper
• Ten-year risk of dementia in subjects with mild cognitive impairment

  2006cited by this paper
• Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources

  2005cited by this paper
• Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.

  2005cited by this paper
• Global prevalence of dementia: a Delphi consensus study

  2005cited by this paper
• Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews.

  2005cited by this paper
• Clinical Features of Frontotemporal Dementia

  2005cited by this paper
• Mild Cognitive Impairment: An Operational Definition and Its Conversion Rate to Alzheimer’s Disease

  2005cited by this paper
• Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Mild cognitive impairment as a diagnostic entity

  2004cited by this paper
• Is MCI really just early dementia? A systematic review of conversion studies

  2004cited by this paper
• Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

  2003cited by this paper
• Mild cognitive impairment

  2003cited by this paper
• Evaluation of diagnostic procedures

  2002cited by this paper
• Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET

  2002cited by this paper
• Current concepts in mild cognitive impairment.

  2001cited by this paper
• A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations

  2001cited by this paper
• Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage alzheimer’s disease

  2001cited by this paper
• SPECT in Alzheimer's disease:features associated with bilateral parietotemporal hypoperfusion

  2000cited by this paper
• The CA1 Region of the Human Hippocampus Is a Hot Spot in Alzheimer's Disease

  2000cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• Frontotemporal lobar degeneration

  1998cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Vascular dementia

  1993cited by this paper
• The Clinical Dementia Rating (CDR)

  1993cited by this paper
• Positron emission tomography in Alzheimer's disease

  1986cited by this paper
• Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).

  2021cites this paper
• Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease

  2020cites this paper
• PET Neuroimaging in Dementia Conditions

  2020cites this paper
• Imaging biomarkers in neurodegeneration: current and future practices

  2020cites this paper
• Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis

  2019cites this paper
• Evidence-based indications for the planning of PET or PET/CT capacities are needed

  2019cites this paper
• 18F-FDG-PET/CT (FDG-PET) in Neurodegenerative Disease

  2019cites this paper
• Molecular Imaging and Targeted Therapy in Neurology

  2019cites this paper
• 18 F-FDG PET for the early diagnosis of Alzheimer ’ s disease dementia and other dementias in people with mild cognitive impairment ( MCI ) Review information Review type : Diagnostic test accuracy Review number : DTA 23

  2018cites this paper
• Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia

  2018cites this paper
• Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI) Review information

  2018cites this paper
• Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease

  2018cites this paper
• The Use of 18F-FDG PET in the Diagnostic Workup of Alzheimer's Dementia.

  2018cites this paper
• Clinical utility of FDG-PET for the clinical diagnosis in MCI

  2018cites this paper
• Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer’s dementia: a meta-analysis

  2018cites this paper
• Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer’s dementia in a memory clinic population

  2018cites this paper
• Designing Radiology Outcomes Studies-Essential Principles.

  2016cites this paper
• Prevention of Alzheimer's Disease and Alzheimer's Dementia

  2016cites this paper
• Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).

  2015cites this paper
• Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis.

  2015cites this paper
• Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer’s Disease

  2015cites this paper
• A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives

  2015cites this paper
• ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

  2014cites this paper
• Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis ( Review )

  year unknowncites this paper